24 January 201720 January 2017 VCs Invest $5.8 Billion in Bio-based Chemicals, as Focus Shifts to Disruptive Synthetic Biology This year, synthetic biology startups have raised 53% of all VC funding in bio-based materials and chemicals, says Lux Research
